Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid malignancy in adults
accounting for 31% of all NHL in Western Countries. Following, morphological, biological …

Primary testicular lymphoma (PTL) is a rare, clinically aggressive form of extranodal
lymphoma. The vast majority of cases are histologically diffuse large B-cell lymphoma, but …

Diffuse large B-cell lymphoma (DLBCL) constitutes 30%–58% of non-Hodgkin's lymphoma
series. The crude incidence in Europe is 3.8/100 000/year [1]. The incidence increases with …

PURPOSE CNS progression or relapse is an uncommon but devastating complication of
aggressive B-cell lymphoma. There is no consensus regarding the optimal approach to CNS …

BACKGROUND: Primary cardiac lymphoma (PCL) represents a rare subset of non‐Hodgkin
lymphoma, characterized by poor outcomes. The authors aimed to construct a framework of …

The aim of these guidelines is to provide practical clinical guidance and recommendations
to clinicians to manage diffuse large B-cell lymphomas (DLBCLs) that arise in extranodal …

Purpose Primary testicular lymphoma (PTL) has poor prognosis with failures in contralateral
testis, CNS, and extranodal sites. To prevent these events, we designed an international …

One thousand two hundred twenty-two patients treated in the Rituximab with CHOP over
age 60 years (RICOVER-60) trial were examined for central nervous system (CNS) disease …

BACKGROUND: The outcome of patients with systemic diffuse large B‐cell lymphoma
(DLBCL) had improved over the past decade with the addition of monoclonal antibody …

Background Primary diffuse large B-cell lymphoma (DLBCL) of breast is rare. We aimed to
define clinical features, prognostic factors, patterns of failure, and treatment outcomes …